Basics |
Humacyte, Inc. Common Stock
|
IPO Date: |
November 30, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$353.67M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.19 | 3.86%
|
Avg Daily Range (30 D): |
$0.08 | 3.38%
|
Avg Daily Range (90 D): |
$0.09 | 4.38%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.37M |
Avg Daily Volume (30 D): |
3.13M |
Avg Daily Volume (90 D): |
4.06M |
Trade Size |
Avg Trade Size (Sh.): |
162 |
Avg Trade Size (Sh.) (30 D): |
241 |
Avg Trade Size (Sh.) (90 D): |
279 |
Institutional Trades |
Total Inst.Trades: |
292 |
Avg Inst. Trade: |
$1.45M |
Avg Inst. Trade (30 D): |
$1.75M |
Avg Inst. Trade (90 D): |
$1.47M |
Avg Inst. Trade Volume: |
.31M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.56M |
Avg Closing Trade (30 D): |
$2.67M |
Avg Closing Trade (90 D): |
$1.92M |
Avg Closing Volume: |
314.79K |
|
|
News |
Mar 26, 2025 @ 10:18 AM
US Stocks Likely To Open Lower After 3-Day Advance...
Source: Rishabh Mishra
|
Jan 21, 2025 @ 3:44 PM
DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ...
Source: The Law Offices Of Frank R. Cruz
|
Jan 17, 2025 @ 5:28 PM
HUMA Investors Have Opportunity to Lead Humacyte, ...
Source: Business Wire
|
Jan 17, 2025 @ 3:47 PM
HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,...
Source: N/A
|
Jan 13, 2025 @ 5:14 PM
Humacyte, Inc. (HUMA) Investors Who Lost Money Hav...
Source: Prnewswire
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$.28
|
$-.16
|
$-1.26
|
Diluted EPS
|
$.28
|
$-.16
|
$-1.26
|
Revenue
|
$ .52M
|
$ M
|
$ M
|
Gross Profit
|
$ .37M
|
$
|
$
|
Net Income / Loss
|
$ 39.14M
|
$ -20.94M
|
$ -148.7M
|
Operating Income / Loss
|
$ -23.18M
|
$ -28.09M
|
$ -114.4M
|
Cost of Revenue
|
$ .15M
|
$
|
$
|
Net Cash Flow
|
$ 17.91M
|
$ 24.37M
|
$ 14.49M
|
PE Ratio
|
9.45
|
|
|
|
|
|